Feasibility of provision and vaccine hesitancy at a central hospital COVID-19 vaccination site in South Africa after four waves of the pandemic

Show simple item record

dc.contributor.author Nair, Shanal
dc.contributor.author Tshabalala, Khanyisile
dc.contributor.author Slingers, Nevilene
dc.contributor.author Vanleeuw, Lieve
dc.contributor.author Basu, Debashis
dc.contributor.author Abdullah, Fareed
dc.date.accessioned 2024-11-07T06:55:49Z
dc.date.available 2024-11-07T06:55:49Z
dc.date.issued 2024-06
dc.description DATA AVAILABILITY STATEMENT : Data supporting reported results can be requested from the authors. en_US
dc.description.abstract BACKGROUND : As mortality declined significantly during the fourth and fifth waves compared to previous waves, the question of the future role of COVID-19 vaccination arose among both experts and the public in South Africa. Turning attention away from the general public, now considered to be at very low risk of severe COVID-19 disease, a commonly held view was that the vaccination campaign should focus only on those who remain highly vulnerable to severe disease and death from COVID-19. Primary amongst this group are patients with common chronic diseases attending hospital outpatient departments. We hypothesized that providing COVID-19 vaccinations on-site at a central hospital will increase uptake for the patients with co-morbid chronic conditions who need them most in the Omicron phase of the pandemic. AIM : Evaluate the acceptability, need, and uptake of a hospital-based vaccination site for patients attending the medical hospital outpatient departments. OBJECTIVES : To assess vaccination uptake, coverage, and hesitancy in people attending a central hospital, to determine factors associated with and influencing vaccination uptake, and to document implementation and assess acceptability of the vaccination project among staff and persons attending the hospital. METHODS : Mixed-methods study using quantitative and qualitative methods. RESULTS : Of the 317 participants enrolled in the study, 229 (72%) had already received at least one dose of the COVID-19 vaccine. A total of 296 participants were eligible for a first vaccination, additional vaccination, or booster vaccination according to the South African Department of Health guidelines. Of those previously vaccinated, 65% opted for an additional dose on the day it was offered (same day). Only 13 previously unvaccinated participants (15% of vaccine naïve participants) opted for vaccination, increasing vaccine coverage with at least one dose from 72% to 76%. Approximately 24% (n = 75) of all participants refused vaccination (vaccine hesitant). Variables tested for an association with vaccination status demonstrated that age reached statistical significance. Emerging themes in the qualitative analysis included perceptions of vulnerability, vaccine safety and efficacy concerns, information gaps regarding vaccinations, the value of convenience in the decision to vaccinate, and the role of health promoters. CONCLUSIONS : This study has shown that it is logistically acceptable to provide a vaccination site at a large hospital targeting patients attending outpatient services for chronic medical conditions. This service also benefits accompanying persons and hospital staff. Access and convenience of the vaccination site influence decision-making, increasing the opportunity to vaccinate. However, vaccine hesitancy is widespread with just under one-quarter of all those offered vaccinations remaining unvaccinated. Strengthening health education and patient–clinician engagement about the benefits of vaccination is essential to reach highly vulnerable populations routinely attending hospital outpatient departments with an appropriate vaccination program. en_US
dc.description.department Internal Medicine en_US
dc.description.department School of Health Systems and Public Health (SHSPH) en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The Rand Merchant Bank through SPIRE, private funding. en_US
dc.description.uri https://www.mdpi.com/journal/diseases en_US
dc.identifier.citation Nair, S.; Tshabalala, K.; Slingers, N.; Vanleeuw, L.; Basu, D.; Abdullah, F. Feasibility of Provision and Vaccine Hesitancy at a Central Hospital COVID-19 Vaccination Site in South Africa after Four Waves of the Pandemic. Diseases 2024, 12, 113. https://doi.org/10.3390/diseases12060113. en_US
dc.identifier.issn 2079-9721 (online)
dc.identifier.other 10.3390/diseases12060113
dc.identifier.uri http://hdl.handle.net/2263/98961
dc.language.iso en en_US
dc.publisher MDPI en_US
dc.rights © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Vaccination en_US
dc.subject Vaccine uptake en_US
dc.subject Vaccine hesitancy en_US
dc.subject Hospitals en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Feasibility of provision and vaccine hesitancy at a central hospital COVID-19 vaccination site in South Africa after four waves of the pandemic en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record